IDH1 and neoplasm: No significant differences in the type or number of mutations were identified that accounted for the different clinical findings associated with IDH1 and IDH2. However, we show that IDH1 tumours are globally more methylated at CpG islands compared to both the IDH2 and IDHwt tumours.